Cell And Gene Therapy Manufacturing

  1. Unlocking The Future Of Allogeneic Cell Therapy For Oncology | Audience Q&A 5/6/2024

    Expert panelists in this Cell & Gene Therapy Live presentation provided detailed responses to questions about the potential risks of CAR-T therapy, screening criteria for donor material, comparability, and more.

  2. Pipeline Progress 8/18/2023

    Experts working on robust pipelines that focus on various therapeutic areas explain how process automation looks different per therapeutic focus area.

  3. BioTitan Retention Device Overview 5/29/2025

    Learn about a retention device that provides robust fortification for single-use assemblies. Its 360-degree seal strengthens connections, reduces leak risks, and ensures process integrity for fluid transfer.

  4. Bioprocessing Solutions For Cell Culture 6/16/2025

    Whatever the scope of your project, you can choose from our unmatched portfolio of high-impact produCTS and services to deliver consistent, scalable solutions.

  5. mRNA For Cancer Immunotherapy 2024 Outlook | Audience Q&A 1/29/2024

    During our Cell & Gene Live, mRNA For Cancer Immunotherapy 2024 Outlook, our expert panelists answered audience questions regarding patient safety, foreseeable challenges in mRNA cancer immunotherapy for solid tumors, and much more.

  6. Mitigating Risk In Process Automation 8/18/2023

    Two Chief Technical Officer's for therapeutic organizations cover the various ways in which automation helps to reduce risk and why closing systems and reducing the number of manual manipulations is so critical.

  7. Thermo Fisher Scientific Suzhou, China Manufacturing Site Capabilities 11/2/2018

    Watch this video to learn more about this manufacturing site capabilities, quality management systems, PPI implementation, product expansion, assurance of supply and lead times.

  8. Achieving Stability For mRNA 1/29/2024

    Expert panelists for this Cell & Gene live event share some of things researchers are exploring to keep mRNA more stable.

  9. Considerations For Affinity Capture In An AAV Platform Downstream Process 6/2/2025

    This presentation explores the considerations when evaluating a platform affinity capture step for the purification of AAV vectors. Specificity, binding capacity, purity, yield, scalability and reusability are parameters that will be addressed.

  10. Interview With Nico Chow And Sandi True, Field Applications Specialists 11/6/2025

    Hear Nico Chow and Sandi True, Field Applications Specialists, discuss working with customers to help them evaluate and implement Residual DNA Quantitation, Mycoplasma Detection, and Microbial Identification Assays.